Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC
Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC
Recruiting · NCT07158489 · Registry updated 2026-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-08-26 | NCT07158489 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Swiss Cancer Institute | 29 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hôpital Fribourgeois - Hôpital Cantonal | Fribourg | Switzerland | 2 |
| Hôpitaux universitaires de Genève | Geneva | Switzerland | 11 |
| IOSI Ospedale Regionale di Bellinzona e Valli | Bellinzona | Switzerland | 5 |
| Kantonsspital Baden | Baden | Switzerland | 29 |
| Kantonsspital Graubuenden | Chur | Switzerland | 7 |
| Kantonsspital Winterthur | Winterthur | Switzerland | 27 |
| Universitätsspital Basel | Basel | Switzerland | 43 |